Internal Medicine
Review | The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology.
14 Sep, 2021 | 09:58h | UTCThe next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology – Nature Medicine
Commentary on Twitter
Important paper. Monitoring virus evolution and assessing variants is critical to guide the response.
Science, collaboration, analyses, sharing, discussion, action, repeat
Proud @WHO provided technical and financial support for it. #COVID19 https://t.co/M7v8dmIy6q https://t.co/j1VOgBhw6Y
— Maria Van Kerkhove (@mvankerkhove) September 10, 2021
Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021.
14 Sep, 2021 | 08:57h | UTC
M-A: Study shows significant risk of major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism.
14 Sep, 2021 | 08:55h | UTCLong-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries:
Long-term Anticoagulation After Unprovoked VTE: New Insights – TCTMD
Extended Anticoagulation Tied to Major Bleeding Risk – HealthDay
Commentary on Twitter
🆕 Delighted to share the MAJESTIC Study providing best available estimates for major bleeding risk during extended #anticoagulation of up to 5 years in patients with unprovoked #VTE (& clinically important subgroups), now published in @AnnalsofIM!https://t.co/Ri2EvZvffq pic.twitter.com/3jvN8mTKSi
— Faizan Khan, PhD (@FaizanK91) September 13, 2021
Viewpoint | The management of multi-morbidity in elderly patients: Ready yet for precision medicine in intensive care?
14 Sep, 2021 | 08:47h | UTC
Antifungal Susceptibility Testing: A Primer for Clinicians.
14 Sep, 2021 | 08:46h | UTCAntifungal Susceptibility Testing: A Primer for Clinicians – Open Forum Infectious Diseases
Commentary on Twitter
New in OFID: An overview for clinicians on antifungal susceptibility testing, including testing methods and their limitations, and how results may or may not be clinically useful.
📄:https://t.co/ZhPL5oQ57F #OpenForumInfectDis #IDSAJournals @PaulSaxMD @DrJLi pic.twitter.com/wrIkBc5MPV
— IDSA (@IDSAInfo) September 11, 2021
Cohort study: Clinical characteristics and prognosis of patients with microvascular angina.
14 Sep, 2021 | 08:49h | UTCNews release: Disease of the smallest heart blood vessels is important global health problem – European Heart Journal
Editorial: Microvascular angina: quo tendimus? – European Heart Journal
‘Do not resuscitate’ decision recorded for only 1 in 5 very sick hospitalized older patients, study finds
14 Sep, 2021 | 08:40h | UTCOriginal study: Do not attempt cardiopulmonary resuscitation (DNACPR) decisions for older medical inpatients: a cohort study – BMJ Supportive & Palliative Care
Four factors that increase the risk of vaccinated people getting COVID.
12 Sep, 2021 | 22:02h | UTCFour factors that increase the risk of vaccinated people getting COVID – The Conversation
What’s the evidence for COVID-19 booster shots?
12 Sep, 2021 | 22:05h | UTCWhat’s the evidence for COVID-19 booster shots? – Canadian Medical Association Journal
Risk of severe breakthrough Covid-19 higher for seniors and people with underlying conditions.
12 Sep, 2021 | 22:03h | UTCRisk of severe breakthrough Covid-19 higher for seniors and people with underlying conditions – CNN
Original study: Hospitalisation among vaccine breakthrough COVID-19 infections – The Lancet Infectious Diseases
News release: Study examines severe breakthrough cases of COVID-19 – YaleNews
Commentary on Twitter
New Comment: Hospitalisation among vaccine breakthrough #COVID19 infections https://t.co/1MtOoO8HVV, by Prerak V Juthani, @hyungjchun, and colleagues pic.twitter.com/mYAAEzHLDL
— The Lancet Infectious Diseases (@TheLancetInfDis) September 8, 2021
Guidelines for the management of iron deficiency anemia in adults.
12 Sep, 2021 | 21:48h | UTC
Among patients with paroxysmal atrial fibrillation, acute consumption of alcohol increases the risk of new episodes.
12 Sep, 2021 | 21:44h | UTCAcute Consumption of Alcohol and Discrete Atrial Fibrillation Events – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries:
Alcohol Consumption and Discrete Atrial Fibrillation Events – American College of Cardiology
Summary for patients: Alcohol Drinking and Atrial Fibrillation – Annals of Internal Medicine
Commentary on Twitter
ICYMI: Even one alcoholic drink associated with immediate increased risk for atrial fibrillation event https://t.co/9Uq87I3fEW. #alcohol #cocktails #afib@docwhitman @gregorymmarcus @SF_POSTSCD pic.twitter.com/Hha0cFvJqc
— Annals of Int Med (@AnnalsofIM) September 2, 2021
Different risks and benefits leading to similar costs after sleeve gastrectomy and Roux-en-Y gastric bypass.
12 Sep, 2021 | 21:37h | UTCOriginal study: Comparison of 4-Year Health Care Expenditures Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy – JAMA Network Open
Commentary on Twitter
Cohort study found that 4-year healthcare expenditures associated with Roux-en-Y gastric bypass (RYGB) surgery and sleeve gastrectomy (SG) did not differ in Ontario, Canada. https://t.co/pegVdcwgJG
— JAMA Network Open (@JAMANetworkOpen) September 9, 2021
Changing the conversation from ‘chronic disease’ to ‘chronic health’.
12 Sep, 2021 | 21:35h | UTCChanging the conversation from ‘chronic disease’ to ‘chronic health’ – European Heart Journal
Commentary on Twitter
Changing the conversation from 'chronic disease' to 'chronic health' https://t.co/cDkTeyRVuh
@LuigiFontana22 and colleagues, yes 👍"Evidence that lifestyle changes markedly improve cardiovascular outcomes… and improved longevity in asymptomatic and known CVD is overwhelming" pic.twitter.com/UoDpq6ogZ9
— Agingdoc⭐David Barzilai🔔MD PhD MS MBA DipABLM🩺 (@agingdoc1) September 8, 2021
RCT: Convalescent plasma does not improve outcomes and may be harmful to hospitalized patients with COVID-19.
10 Sep, 2021 | 05:37h | UTCNews release: Major study finds convalescent plasma doesn’t help seriously ill COVID-19 patients – McMaster University
Related:
M-A: Convalescent plasma is safe but does not improve outcomes in the treatment of COVID-19.
RECOVERY Trial: No benefit from convalescent plasma in patients admitted to hospital with COVID-19.
Commentary on Twitter
A randomized trial in patients hospitalized with COVID-19 showed no benefit and potentially increased harm associated with the use of convalescent plasma, according to a @NatureMedicine paper. https://t.co/7JFhEXLmbA pic.twitter.com/Q3e50Q0I7T
— Nature Portfolio (@NaturePortfolio) September 9, 2021
Face masks for COVID pass their largest test yet – “A rigorous study finds that surgical masks are highly protective, but cloth masks fall short”.
10 Sep, 2021 | 05:36h | UTCFace masks for COVID pass their largest test yet – Nature
Original study: [Preprint] Largest study of masks yet details their importance in fighting Covid-19.
Commentary on Twitter
Face masks for COVID pass their largest test yet – I & others comment. It is true that I bought pink surgical masks (my favorite color) in response to this study for when I am around unvaccinated adults (or indoor public spaces for now)https://t.co/nFhlcqwrjv
— Monica Gandhi MD, MPH (@MonicaGandhi9) September 9, 2021
Covid-19: Infection increases the risk of kidney disease even in mild cases, finds study.
10 Sep, 2021 | 05:33h | UTCCovid-19: Infection increases the risk of kidney disease even in mild cases, finds study – The BMJ
Original study: Kidney Outcomes in Long COVID – Journal of the American Society of Nephrology
Long COVID and kidney disease.
10 Sep, 2021 | 05:31h | UTCLong COVID and kidney disease – Nature Reviews Nephrology
COVID infections may give more potent immunity than vaccines – but that doesn’t mean you should try to catch it.
10 Sep, 2021 | 05:29h | UTCOriginal study and commentary: [Preprint] Observational data suggests natural immunity after a SARS-CoV-2 infection confers longer lasting and stronger protection compared to vaccine-induced immunity.
Guideline: Medical cannabis or cannabinoids for chronic pain.
10 Sep, 2021 | 05:22h | UTCMedical cannabis or cannabinoids for chronic pain: a clinical practice guideline – The BMJ
Editorial: Medical cannabis for chronic pain – The BMJ
Related: Cannabis and Cannabinoid Analgesia position statement – “Due to the lack of high-quality clinical evidence, the IASP does not currently endorse general use of cannabis and cannabinoids for pain relief.” (several resources on the subject)
Commentary on Twitter
A panel of international experts make a weak recommendation for a trial of non-inhaled medical cannabis or cannabinoids for people living with chronic pain, if standard care is not sufficient
Guideline includes a visual summary #BMJInfographic @will_s_t https://t.co/25ML4DZcvz pic.twitter.com/mjbDOyYVLL
— The BMJ (@bmj_latest) September 9, 2021
Perspective | What we actually know about waning immunity.
10 Sep, 2021 | 05:26h | UTCWhat We Actually Know About Waning Immunity – The Atlantic
Topic-based, recent literature review on pulmonary hypertension.
10 Sep, 2021 | 05:06h | UTCTopic-Based, Recent Literature Review on Pulmonary Hypertension – Mayo Clinic Proceedings
Stress testing and noninvasive coronary imaging: What’s the best test for my patient?
10 Sep, 2021 | 05:01h | UTC
[Preprint] Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera.
9 Sep, 2021 | 10:02h | UTCIneffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera – bioRxiv
Related: United States boosts tracking of coronavirus strains as Mu variant draws scrutiny – Science
Commentary on Twitter (thread – click for more)
📍Bad news on #MuVariant—Japanese scientists: "Mu variant is highly resistant to sera from convalescent & [Pfizer]-vaccinated people. Direct comparison of different spike proteins revealed that Mu spike is more resistant…than all other current variants”🧵https://t.co/Ilf5gh3OGd pic.twitter.com/DbdJVGZTjz
— Eric Feigl-Ding (@DrEricDing) September 8, 2021
New Canadian study confirms the excess mortality associated with eating disorders.
10 Sep, 2021 | 05:03h | UTCNew Canadian study confirms the excess mortality associated with eating disorders – The Mental Elf
Original study: Excess mortality associated with eating disorders: population-based cohort study – The British Journal of Psychiatry
Commentary on Twitter
Today, @annapaspala1 summarises a new study by @KurdyakP et al, published today in @TheBJPsych, which suggests that in Ontario (Canada), mortality rates in people with eating disorders were 5-7 times higher than the general population.https://t.co/P2QmU3Qxg8 pic.twitter.com/7VrpsevF5P
— The Mental Elf (@Mental_Elf) September 1, 2021


